SUSRF (Surgical Science Sweden AB) Tariff Resilience Score: 7/10 (As of Jun. 29, 2026)


SUSRF Surgical Science Sweden AB SUSRF
82 GF Score
Price $4.00
GF Value $19.33
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB Tariff Resilience Score?

Surgical Science Sweden AB SUSRF -2.20% 82 Tariff Resilience Score is 7 as of Jun. 29, 2026. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $19.33 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 674 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks better than 89.17% on this metric.

Surgical Science Sweden AB has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Surgical Science Sweden AB has Medical simulation products with global sales. Some exposure to tariffs on components but mitigated by high-value products and potential for alternative suppliers.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Surgical Science Sweden AB might have Highly Resilient.

Surgical Science Sweden AB  (OTCPK:SUSRF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Surgical Science Sweden AB Tariff Resilience Score Related Terms

SUSRF vs VEEV, BTSG, TEM: Tariff Resilience Score Comparison

For the Health Information Services subindustry, Surgical Science Sweden AB's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgical Science Sweden AB Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's Tariff Resilience Score falls into.


SUSRF
82GF Score
Surgical Science Sweden AB SUSRF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Surgical Science Sweden AB (SUSRF) has a Tariff Resilience Score of 7 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Surgical Science Sweden AB ranks #73 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 10.8%.
Is Surgical Science Sweden AB's Tariff Resilience Score too high?
Surgical Science Sweden AB's current Tariff Resilience Score is 7. Based on the distribution chart, Surgical Science Sweden AB ranks #73 out of 674 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Tariff Resilience Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #73 out of 674 companies for Tariff Resilience Score. This places Surgical Science Sweden AB in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Surgical Science Sweden AB's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.33, compared to a current price of $4.00 — trading 79.3% below its estimated fair value. The current Tariff Resilience Score is 7. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Tariff Resilience Score is 7 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of $4.00 is trading 79.3% below its estimated GF Value™ of $19.33. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for SUSRF:

  • Tariff Resilience Score: 7
  • GF Value™: $19.33 vs. price of $4.00 (79.3% below fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Surgical Science Sweden AB Business Description

Other Exchanges SUS:Sweden4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score

Get the complete analysis for SUSRF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price
$19.33
GF Value